Metabolic fate of chylomicron phospholipids and apoproteins in the rat.

To study the metabolic fate of chylomicron phospholipid and apoproteins, 15 mg of doubly labeled ([(3)H]leu, [(32)P]phospholipid) rat mesenteric lymph chylomicrons were injected as an intravenous bolus into conscious rats. The specific radioactivity, composition, pool size, and morphology of the plasma lipoproteins were determined after 2-60 min. After injection of chylomicrons, there was a rapid transfer of radioactivity into high density lipoproteins (HDL). At peak specific activity in HDL (2-5 min), 35% of injected apoprotein and 25% of phospholipid radioactivity were recovered in HDL (d 1.063-1.21 g/ml), with smaller recoveries in other lipoproteins and liver. There was an initial rapid rise of (32)P specific activity in HDL and d 1.02-1.063 lipoproteins (low density lipoproteins [LDL]), but whereas LDL specific activity subsequently converged with that of d < 1.02 lipoproteins, HDL specific activity decayed more rapidly than LDL or d < 1.02 lipoproteins. Lipolysis of chylomicrons was associated with a transfer of phospholipid mass into LDL and HDL. At 5 min, 80% of injected triglyceride had been lipolyzed and there was a significant increase in phospholipid mass in LDL and a smaller increase in HDL. At 10 min, the mass of phospholipid in LDL had returned towards control values, and there was a further increase in phospholipid mass in HDL, which suggested phospholipid transfer from LDL to HDL. In donor lymph chylomicrons (3)H-radioactivity was present in apoprotein (apo)B, apoA-I, and apoA-IV, but only radioactivity of apoA-I and apoA-IV were transferred to HDL. Transfer of radioactivity was associated with loss of mass of apoA-I and apoA-IV from the fraction that contained the chylomicron remnants (d < 1.02). With injection of 15 mg chylomicron, there was a small but insignificant increase in the relatively large pool of HDL apoA-I. However, 60 min after injection of 250 mg of human or rat intestinal chylomicrons into the rat, there was a significant increase in HDL apoA-I that resulted from acquisition of a major fraction of the chylomicron apoA-I. After injection of chylomicrons, phospholipid vesicles were observed by negative stain electron microscopy in the LDL and HDL ultracentrifugal fractions, especially in the LDL. Upon addition of an osmotically active compound, cellobiose, vesicles were observed as flattened particles with a double lipid bilayer thickness ( congruent with 100 A). To validate further the identity of these particles, chylomicrons were injected into rats with [(3)H]glucose, and the recipient rats' plasma was fractionated by chromatography on 6% agarose. Trapping of [(3)H]glucose occurred in the void and LDL regions of the column, and vesicular particles were identified in these column fractions by negative stain electron microscopy. Catabolism of chylomicrons is associated with a rapid transfer of phospholipid, apoA-I, and possibly apoA-IV into HDL. Chylomicron phospholipid appears to give rise to vesicles which are probably incorporated into preexisting HDL. Chylomicron surface components may be an important source of plasma HDL.

[1]  A. Tall,et al.  Human intestinal lipoproteins. Studies in chyluric subjects. , 1979, The Journal of clinical investigation.

[2]  A. Lopez-s Treatment of hyperlipidemias. , 1979, The Journal of the Louisiana State Medical Society.

[3]  A. Tall,et al.  Interaction between unilamellar egg yolk lecithin vesicles and human high density lipoprotein. , 1979, Biochemistry.

[4]  R. Lees,et al.  Apoprotein A-I synthesis in normal intestinal mucosa and in Tangier disease. , 1978, The New England journal of medicine.

[5]  D. Fredrickson,et al.  Tangier disease: one explanation of lipid storage. , 1978, The New England journal of medicine.

[6]  E. Schaefer,et al.  Lipoprotein apoprotein metabolism. , 1978, Journal of lipid research.

[7]  J. Little,et al.  Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. , 1978, The New England journal of medicine.

[8]  S. Eisenberg,et al.  Very low density lipoprotein. Metabolism of phospholipids, cholesterol, and apolipoprotein C in the isolated perfused rat heart. , 1978, The Journal of clinical investigation.

[9]  G. Schonfeld,et al.  Intestinal apoproteins during fat absorption. , 1978, The Journal of clinical investigation.

[10]  H. G. Windmueller,et al.  Identification of circulating apolipoproteins synthesized by rat small intestine in vivo. , 1978, The Journal of biological chemistry.

[11]  A. Tall,et al.  Rat intestine secretes discoid high density lipoprotein. , 1978, The Journal of clinical investigation.

[12]  H. Brewer,et al.  Human chylomicron apolipoprotein metabolism. , 1978, Biochemical and biophysical research communications.

[13]  A. Tall,et al.  Interaction of plasma high density lipoproteins with dimyristoyllecithin multilamellar liposomes. , 1978, Biochemistry.

[14]  F. Frey,et al.  Selective deficiency of hepatic triglyceride lipase in uremic patients. , 1977, The New England journal of medicine.

[15]  C. Blum,et al.  High density lipoprotein metabolism in man. , 1977, The Journal of clinical investigation.

[16]  P. Green,et al.  The intestine as a source of apolipoprotein A1. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M C Hjortland,et al.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. , 1977, The American journal of medicine.

[18]  D. Ballantyne,et al.  On the rise in low density and high density lipoproteins in response to the treatment of hypertriglyceridaemias in type IV and type V hyperlipoproteinaemias. , 1977, Atherosclerosis.

[19]  S. Sabesin,et al.  Abnormal plasma lipoproteins and lecithin-cholesterol acyltransferase deficiency in alcoholic liver disease. , 1977, Gastroenterology.

[20]  A. Tall,et al.  Solubilisation of phospholipid membranes by human plasma high density lipoproteins , 1977, Nature.

[21]  W. Haskell,et al.  The distribution of plasma lipoproteins in middle-aged male runners. , 1976, Metabolism: clinical and experimental.

[22]  A. Chobanian,et al.  The in vivo transformation of phospholipid vesicles to a particle resembling HDL in the rat. , 1976, Biochemical and Biophysical Research Communications - BBRC.

[23]  R. Havel,et al.  Discoidal bilayer structure of nascent high density lipoproteins from perfused rat liver. , 1976, The Journal of clinical investigation.

[24]  G. Shipley,et al.  Physical chemistry of the lipids of human atherosclerotic lesions. Demonstration of a lesion intermediate between fatty streaks and advanced plaques. , 1976, The Journal of clinical investigation.

[25]  A Kagan,et al.  Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. , 1976, The New England journal of medicine.

[26]  G. Miller,et al.  PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE , 1975, The Lancet.

[27]  K. Kirsch,et al.  Lymph chylomicron formation during the inhibition of protein synthesis. Studies of chylomicron apoproteins. , 1973, The Journal of clinical investigation.

[28]  R. Scow,et al.  EFFECTS OF LIPOPROTEIN LIPASE ON THE STRUCTURE OF CHYLOMICRONS , 1973, The Journal of cell biology.

[29]  R. Lees,et al.  Metabolic relationships among the plasma lipoproteins. Reciprocal changes in the concentrations of very low and low density lipoproteins in man. , 1972, The Journal of clinical investigation.

[30]  E. Gong,et al.  Electron microscopic study on reassembly of plasma high density apoprotein with various lipids. , 1971, Biochimica et biophysica acta.

[31]  R. Havel,et al.  Cholestasis: Lamellar Structure of the Abnormal Human Serum Lipoprotein , 1971, Science.

[32]  T. Redgrave Formation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons. , 1970, The Journal of clinical investigation.

[33]  E. H. Strisower,et al.  Treatment of hyperlipidemias. , 1968, The American journal of medicine.

[34]  S. Eisenberg,et al.  The role of lysolecithin in phospholipid metabolism of human umbilical and dog carotid arteries. , 1967, Biochimica et biophysica acta.

[35]  O. Stein,et al.  Metabolism of labeled lysolecithin, lysophosphatidyl ethanolamine and lecithin in the rat. , 1966, Biochimica et biophysica acta.

[36]  R. Havel,et al.  METABOLISM OF CONSTITUENT LIPIDS OF DOG CHYLOMICRONS. , 1963, The Journal of clinical investigation.

[37]  R. Havel,et al.  SITES OF INITIAL REMOVAL OF CHYLOMICRON TRIGLYCERIDE FATTY ACIDS FROM THE BLOOD. , 1962, The Journal of clinical investigation.

[38]  R. Havel Early effects of fat ingestion on lipids and lipoproteins of serum in man. , 1957, The Journal of clinical investigation.

[39]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[40]  D. Hegsted,et al.  Normal blood volume, plasma volume and thiocyanate space in rats and their relation to body weight. , 1949, American Journal of Physiology.

[41]  R. Scow,et al.  Retention of lipolytic products in chylomicrons incubated with lipoprotein lipase: electron microscope study. , 1976, Journal of lipid research.

[42]  J. Glomset,et al.  The metabolic role of lecithin: cholesterol acyltransferase: perspectives from pathology. , 1973, Advances in lipid research.

[43]  R. Havel,et al.  Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man. , 1973, The Journal of clinical investigation.

[44]  G. Shipley,et al.  Small-angle x-ray scattering of human serum high-density lipoproteins. , 1972, Journal of supramolecular structure.

[45]  D. Downing,et al.  Photodensitometry in the thin-layer chromatographic analysis of neutral lipids. , 1968, Journal of chromatography.

[46]  R. Lees,et al.  The nature of pre beta (very low density) lipoproteins. , 1966, The Journal of clinical investigation.